Skip to main content
. 2020 Aug 11;8:943. doi: 10.3389/fbioe.2020.00943

FIGURE 4.

FIGURE 4

Therapeutic efficiency of T-MNPs. Therapeutic capabilities of T-MNPs, D-MNPs, A-MNPs, NNPs and free Trametinib on (A) 1520 melanoma cell line and (B) DM-6 melanoma cell lines. Cell were exposed to the nanoparticle suspensions for 72 h (ranging concentrations from IC25 to IC75), and cell viability was evaluated using MTS assays. *Statistically significant with P < 0.05.